Found: 72
Select item for more details and to access through your institution.
CSF markers YKL40, sTREM2, and a‐synuclein enhance the Alzheimer's disease A/T/N criteria to detect early changes in cognition.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082891
- By:
- Publication type:
- Article
Brain‐age prediction and its associations with glial and synaptic CSF markers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078194
- By:
- Publication type:
- Article
Brain‐age prediction and its associations with glial and synaptic CSF markers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081795
- By:
- Publication type:
- Article
Large‐scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 12, p. 5447, doi. 10.1002/alz.13130
- By:
- Publication type:
- Article
The potential clinical value of plasma biomarkers in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 12, p. 5805, doi. 10.1002/alz.13455
- By:
- Publication type:
- Article
Neuroimaging of tissue microstructure as a marker of neurodegeneration in the AT(N) framework: defining abnormal neurodegeneration and improving prediction of clinical status.
- Published in:
- Alzheimer's Research & Therapy, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13195-023-01281-y
- By:
- Publication type:
- Article
Blood‐based biomarkers in Alzheimer's disease: Future directions for implementation.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023, v. 15, n. 4, p. 1, doi. 10.1002/dad2.12508
- By:
- Publication type:
- Article
CSF metabolites associated with biomarkers of Alzheimer's disease pathology.
- Published in:
- Frontiers in Aging Neuroscience, 2023, p. 1, doi. 10.3389/fnagi.2023.1214932
- By:
- Publication type:
- Article
Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 9, p. 969, doi. 10.1001/jamaneurol.2023.2338
- By:
- Publication type:
- Article
Neuropathology‐based APOE genetic risk score better quantifies Alzheimer's risk.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 8, p. 3406, doi. 10.1002/alz.12990
- By:
- Publication type:
- Article
Improving statistical modeling with a neuropathology‐based APOE genetic risk score.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.060701
- By:
- Publication type:
- Article
Cerebrospinal fluid soluble TREM2 is associated with accelerated AD‐related longitudinal neurodegeneration in preclinical Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.068312
- By:
- Publication type:
- Article
Biological brain age prediction using machine learning on structural neuroimaging data: Multi-cohort validation against biomarkers of Alzheimer’s disease and neurodegeneration stratified by sex.
- Published in:
- eLife, 2023, p. 1, doi. 10.7554/eLife.81067
- By:
- Publication type:
- Article
Impact of asthma on the brain: evidence from diffusion MRI, CSF biomarkers and cognitive decline.
- Published in:
- Brain Communications, 2023, v. 5, n. 3, p. 1, doi. 10.1093/braincomms/fcad180
- By:
- Publication type:
- Article
Identification of plasma metabolites associated with modifiable risk factors and endophenotypes reflecting Alzheimer's disease pathology.
- Published in:
- European Journal of Epidemiology, 2023, v. 38, n. 5, p. 559, doi. 10.1007/s10654-023-00988-4
- By:
- Publication type:
- Article
An accurate fully automated panel of plasma biomarkers for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 4, p. 1204, doi. 10.1002/alz.12751
- By:
- Publication type:
- Article
Clinical performance and robustness evaluation of plasma amyloid‐β<sub>42/40</sub> prescreening.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 4, p. 1393, doi. 10.1002/alz.12801
- By:
- Publication type:
- Article
Impact of pre‐analytical sample handling factors on plasma biomarkers of Alzheimer's disease.
- Published in:
- Journal of Neurochemistry, 2023, v. 165, n. 1, p. 95, doi. 10.1111/jnc.15757
- By:
- Publication type:
- Article
Test‐retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 3, p. 797, doi. 10.1002/alz.12706
- By:
- Publication type:
- Article
Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit.
- Published in:
- Alzheimer's Research & Therapy, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13195-023-01168-y
- By:
- Publication type:
- Article
Becoming physically active or maintaining physical activity during midlife is associated with biomarkers of amyloid‐beta, microglia, and temporal lobe integrity.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 1, doi. 10.1002/alz.061005
- By:
- Publication type:
- Article
The Effects of Stressful Life Events on Alzheimer's Disease Biomarkers, Neuroinflammation and Brain Integrity in Later Life: A Life Course Perspective.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 1, doi. 10.1002/alz.062129
- By:
- Publication type:
- Article
Sex differences in CSF biomarkers profile of accelerated biological aging individuals at risk of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 1, doi. 10.1002/alz.063082
- By:
- Publication type:
- Article
Air pollution has a more deleterious effect on Alzheimer's disease biomarkers in genetic predisposition to larger hippocampal volumes.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 1, doi. 10.1002/alz.063146
- By:
- Publication type:
- Article
Associations between semantic memory for proper names in story recall and CSF amyloid and tau in a cognitively unimpaired sample.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 7, p. 1, doi. 10.1002/alz.059439
- By:
- Publication type:
- Article
Clinical performance and robustness of blood‐based biomarkers for early detection of amyloid pathology associated with Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.069052
- By:
- Publication type:
- Article
Roadmap to implementation of a fully automated blood‐based biomarker test to facilitate diagnosis and treatment in early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.069080
- By:
- Publication type:
- Article
Current diagnostic pathways for Alzheimer's Disease ‐ A comparison of six countries.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.069278
- By:
- Publication type:
- Article
Gut microbe‐modulated metabolites are longitudinally associated with higher neurodegeneration biomarkers in cerebrospinal fluid (CSF).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.067893
- By:
- Publication type:
- Article
Modifying effect of AD pathology in the association between CSF synaptic biomarkers and brain function and structure in preclinical Alzheimer.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.065600
- By:
- Publication type:
- Article
Predicting CSF neurogranin and neurofilament light chain protein levels with a neuropathology‐based APOE genetic risk score.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.069116
- By:
- Publication type:
- Article
Impact of pre‐analytical factors on blood‐based biomarkers of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.063067
- By:
- Publication type:
- Article
Genetically predicted telomere length and Alzheimer's disease endophenotypes: a Mendelian randomization study.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01101-9
- By:
- Publication type:
- Article
Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer's continuum.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4567, doi. 10.1007/s00259-022-05897-4
- By:
- Publication type:
- Article
Brain alterations in the early Alzheimer's continuum with amyloid-β, tau, glial and neurodegeneration CSF markers.
- Published in:
- Brain Communications, 2022, v. 4, n. 3, p. 1, doi. 10.1093/braincomms/fcac134
- By:
- Publication type:
- Article
Crosswalk study on blood collection‐tube types for Alzheimer's disease biomarkers.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12266
- By:
- Publication type:
- Article
Associations between diffusion MRI microstructure and cerebrospinal fluid markers of Alzheimer's disease pathology and neurodegeneration along the Alzheimer's disease continuum.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12381
- By:
- Publication type:
- Article
Asthma amplifies dementia risk: Evidence from CSF biomarkers and cognitive decline.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022, v. 8, n. 1, p. 1, doi. 10.1002/trc2.12315
- By:
- Publication type:
- Article
Association of body mass index with brain structure and biomarkers of inflammation in cognitively unimpaired middle‐aged adults with and without evidence of β‐amyloid pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.053531
- By:
- Publication type:
- Article
Associations between obstructive sleep apnea, Alzheimer's disease pathology, and objective daytime sleepiness measured by the psychomotor vigilance task in cognitively unimpaired adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054431
- By:
- Publication type:
- Article
Higher levels of the astrocytic marker CSF YKL40 are associated with better memory performance only in amyloid‐positive individuals with subjective cognitive decline.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.053463
- By:
- Publication type:
- Article
Amyloid time: Quantifying the onset of abnormal biomarkers and cognitive impairment along the Alzheimer's disease continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056269
- By:
- Publication type:
- Article
Amyloid aggregation in temporal regions is associated with longitudinal memory decline in cognitively unimpaired Apoe‐ε4 carriers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057546
- By:
- Publication type:
- Article
Synergistic effects of CSF Aβ42 and p‐Tau on functional resting‐state connectivity in cognitively unimpaired individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.053650
- By:
- Publication type:
- Article
Effects of APOE genotype, age and sex on cerebrospinal fluid biomarkers measured with NeuroToolKit in the Longitudinal Swedish Biofinder Cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055153
- By:
- Publication type:
- Article
CSF amyloid, tau, and neurodegeneration biomarkers are associated with longitudinal cognitive decline in preclinical AD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055486
- By:
- Publication type:
- Article
Brain structural alterations in cognitively unimpaired individuals with discordant amyloid‐β PET and CSF Aβ42 status: Findings using machine learning.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.053588
- By:
- Publication type:
- Article
CSF metabolites associated with CSF NeuroToolKit biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056300
- By:
- Publication type:
- Article
Distinctive effect of biological sex in AD‐related CSF and plasma biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.052959
- By:
- Publication type:
- Article
CSF sphingomyelin metabolites in Alzheimer's disease, neurodegeneration, and neuroinflammation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.052290
- By:
- Publication type:
- Article